Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 30 July 2019
Author/s

author: John D Davis  Marie-Louise A Schuttelaar  Andrew Blauvelt  Michihiro Hide 

Publication date July 30, 2019
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item